The funds will be used to build the health system’s new Comprehensive Center for Surgical Innovation, which aims to develop and commercialize new surgical technology and instruments. The center will build upon Mount Sinai’s work through BioDesign, which focuses on developing technological treatments for patients.
“We are thrilled to award this funding to Mount Sinai Health System to launch the Comprehensive Center for Surgical Innovation,” NYCEDC President and CEO Andrew Kimball said in an Aug. 25 press release. “Strategic investments like this by NYCEDC’s LifeSci NYC initiative bridge research, innovative technologies, commercialization, and education to support biomedical leaders to advance groundbreaking research and health care technologies in New York City. We look forward to the startups, jobs, and life changing medical devices this Center will yield to support patient care and treatment.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
